C214H226F4N38O24 — CID 167648673
4-[(6-fluoro-2-pyridinyl)methyl]-N-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;4-[(6-fluoro-2-pyridinyl)methyl]-N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;1-[(Z)-2-[(6-fluoro-3-pyridinyl)methyl]-3-iminoprop-1-enyl]-3-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]urea;1-[(Z)-2-[(6-fluoro-3-pyridinyl)methyl]-3-iminoprop-1-enyl]-3-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]urea;1-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-3-[(Z)-2-methanimidoyl-3-(6-methyl-3-pyridinyl)prop-1-enyl]urea;1-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-3-[(Z)-2-methanimidoyl-3-pyridin-3-ylprop-1-enyl]urea;N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-3-pyridinyl)methyl]pyrazole-1-carboxamide;N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-(pyridin-3-ylmethyl)pyrazole-1-carboxamide (PubChem CID 167648673) has the molecular formula C214H226F4N38O24 and a molecular weight of 3790.40 g/mol. Its IUPAC name is 4-[(6-fluoro-2-pyridinyl)methyl]-N-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;4-[(6-fluoro-2-pyridinyl)methyl]-N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;1-[(Z)-2-[(6-fluoro-3-pyridinyl)methyl]-3-iminoprop-1-enyl]-3-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]urea;1-[(Z)-2-[(6-fluoro-3-pyridinyl)methyl]-3-iminoprop-1-enyl]-3-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]urea;1-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-3-[(Z)-2-methanimidoyl-3-(6-methyl-3-pyridinyl)prop-1-enyl]urea;1-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-3-[(Z)-2-methanimidoyl-3-pyridin-3-ylprop-1-enyl]urea;N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-3-pyridinyl)methyl]pyrazole-1-carboxamide;N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-(pyridin-3-ylmethyl)pyrazole-1-carboxamide.
| Compound Name | 4-[(6-fluoro-2-pyridinyl)methyl]-N-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;4-[(6-fluoro-2-pyridinyl)methyl]-N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;1-[(Z)-2-[(6-fluoro-3-pyridinyl)methyl]-3-iminoprop-1-enyl]-3-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]urea;1-[(Z)-2-[(6-fluoro-3-pyridinyl)methyl]-3-iminoprop-1-enyl]-3-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]urea;1-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-3-[(Z)-2-methanimidoyl-3-(6-methyl-3-pyridinyl)prop-1-enyl]urea;1-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-3-[(Z)-2-methanimidoyl-3-pyridin-3-ylprop-1-enyl]urea;N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-3-pyridinyl)methyl]pyrazole-1-carboxamide;N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-(pyridin-3-ylmethyl)pyrazole-1-carboxamide |
|---|---|
| PubChem CID | 167648673 |
| Molecular Formula | C214H226F4N38O24 |
| Molecular Weight | 3790.40 g/mol |
| Exact Mass | 3787.76 |
| IUPAC Name | 4-[(6-fluoro-2-pyridinyl)methyl]-N-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;4-[(6-fluoro-2-pyridinyl)methyl]-N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;1-[(Z)-2-[(6-fluoro-3-pyridinyl)methyl]-3-iminoprop-1-enyl]-3-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]urea;1-[(Z)-2-[(6-fluoro-3-pyridinyl)methyl]-3-iminoprop-1-enyl]-3-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]urea;1-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-3-[(Z)-2-methanimidoyl-3-(6-methyl-3-pyridinyl)prop-1-enyl]urea;1-[(3R)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-3-[(Z)-2-methanimidoyl-3-pyridin-3-ylprop-1-enyl]urea;N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-3-pyridinyl)methyl]pyrazole-1-carboxamide;N-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-(pyridin-3-ylmethyl)pyrazole-1-carboxamide |
| SMILES | CN1C(=O)C(NC(=O)c2cc(Cc3cccc(F)n3)ccn2)CCc2ccc(C#CC(C)(C)O)cc21.CN1C(=O)C(NC(=O)n2cc(Cc3cccnc3)cn2)CCc2ccc(C#CC(C)(C)O)cc21.CN1C(=O)[C@H](NC(=O)c2cc(Cc3cccc(F)n3)ccn2)CCc2ccc(C#CC(C)(C)O)cc21.Cc1ccc(Cc2cnn(C(=O)NC3CCc4ccc(C#CC(C)(C)O)cc4N(C)C3=O)c2)cn1.[H]/N=C/C(=C\NC(=O)NC1CCc2ccc(C#CC(C)(C)O)cc2N(C)C1=O)Cc1ccc(F)nc1.[H]/N=C/C(=C\NC(=O)N[C@@H]1CCc2ccc(C#CC(C)(C)O)cc2N(C)C1=O)Cc1ccc(C)nc1.[H]/N=C/C(=C\NC(=O)N[C@@H]1CCc2ccc(C#CC(C)(C)O)cc2N(C)C1=O)Cc1ccc(F)nc1.[H]/N=C/C(=C\NC(=O)N[C@@H]1CCc2ccc(C#CC(C)(C)O)cc2N(C)C1=O)Cc1cccnc1 |
| InChI | InChI=1S/2C28H27FN4O3.C27H29N5O3.C27H31N5O3.2C26H28FN5O3.C26H27N5O3.C26H29N5O3/c2*1-28(2,36)13-11-18-7-8-20-9-10-22(27(35)33(3)24(20)17-18)32-26(34)23-16-19(12-14-30-23)15-21-5-4-6-25(29)31-21;1-18-5-6-20(15-28-18)13-21-16-29-32(17-21)26(34)30-23-10-9-22-8-7-19(11-12-27(2,3)35)14-24(22)31(4)25(23)33;1-18-5-6-20(16-29-18)13-21(15-28)17-30-26(34)31-23-10-9-22-8-7-19(11-12-27(2,3)35)14-24(22)32(4)25(23)33;2*1-26(2,35)11-10-17-4-6-20-7-8-21(24(33)32(3)22(20)13-17)31-25(34)30-16-19(14-28)12-18-5-9-23(27)29-15-18;1-26(2,34)11-10-18-6-7-21-8-9-22(24(32)30(3)23(21)14-18)29-25(33)31-17-20(16-28-31)13-19-5-4-12-27-15-19;1-26(2,34)11-10-18-6-7-21-8-9-22(24(32)31(3)23(21)14-18)30-25(33)29-17-20(15-27)13-19-5-4-12-28-16-19/h2*4-8,12,14,16-17,22,36H,9-10,15H2,1-3H3,(H,32,34);5-8,14-17,23,35H,9-10,13H2,1-4H3,(H,30,34);5-8,14-17,23,28,35H,9-10,13H2,1-4H3,(H2,30,31,34);2*4-6,9,13-16,21,28,35H,7-8,12H2,1-3H3,(H2,30,31,34);4-7,12,14-17,22,34H,8-9,13H2,1-3H3,(H,29,33);4-7,12,14-17,22,27,34H,8-9,13H2,1-3H3,(H2,29,30,33)/b;;;21-17-,28-15+;2*19-16-,28-14+;;20-17-,27-15+/t22-;;;23-;21-;;;22-/m1..11..1/s1 |
| InChIKey | QGHDAVQQYFFPCI-NAFMESMVSA-N |
| XLogP | 22.25 |
| TPSA | 865.18 Ų |
| H-Bond Donors | 24 |
| H-Bond Acceptors | 42 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 280 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3790.40 |
| LogP ≤ 5 | 22.25 |
| H-Bond Donors ≤ 5 | 24 |
| H-Bond Acceptors ≤ 10 | 42 |